Kalaris Therapeutics（KLRS.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

风投/私募54.11%
机构投资者16.21%
公众及其他14.24%
个人与内部人士6.02%
其他9.41%

主要股东

主要股东最新
股东
Samsara BioCapital LLC	54.22%	1,290.06 万	2.09%	-4.75 万	2026/05/20
RTW Investments, LP	5.46%	130.00 万	0.21%	+0	2026/03/31
ElevateBio, LLC	3.05%	72.50 万	0.11%	+0	2026/04/01
Paradigm Biocapital Advisors LP	2.94%	70.00 万	0.11%	+0	2026/03/31
Alyeska Investment Group, L.P.	2.41%	57.27 万	0.64%	+16.91 万	2026/03/31
Samir PatelFormer Director & Co-Founder	2.22%	52.83 万	0.09%	+0	2025/03/18
Napoleone FerraraIndependent Director & Co-Founder	2.12%	50.40 万	0.07%	+0	2026/04/01
Vanguard Capital Management, LLC	1.95%	46.49 万	0.68%	+17.28 万	2026/06/30
Artal Group S.A.	1.83%	43.58 万	0.06%	+0	2026/06/30
Ikarian Capital, LLC	1.51%	36.00 万	0.06%	+0	2026/03/31
UBS Asset Management AG	1.10%	26.21 万	1.07%	+25.59 万	2026/06/30
Morana Jovan-EmbiricosFormer Independent Director	0.91%	21.57 万	0.03%	+0	2026/04/01
Renaissance Technologies LLC	0.63%	14.94 万	0.34%	+8.32 万	2026/06/30
Marshall Wace LLP	0.59%	13.92 万	0.29%	+7.13 万	2026/06/30
Kalehua Capital Management LLC	0.57%	13.56 万	0.04%	-4,316.00	2026/03/31
David HallalIndependent Chairman of the Board	0.55%	13.06 万	0.02%	+0	2026/04/01
Globeways Holdings II Limited	0.53%	12.64 万	0.02%	+0	2026/04/01
Raymond James Financial, Inc.	0.50%	11.89 万	0.11%	+3.05 万	2026/03/31
Geode Capital Management, LLC	0.48%	11.40 万	0.10%	+2.65 万	2026/06/30
The Goldman Sachs Group, Inc.	0.42%	10.02 万	0.01%	+0	2026/06/30